Direct-to-Consumer Advertising of Prescription Medications: Implications for Patients With Cancer

2002 ◽  
Vol 29 (3) ◽  
pp. 505-513 ◽  
Author(s):  
Pamela Hallquist Viale
Author(s):  
Beverly Moy ◽  
Reshma Jagsi ◽  
Richard B. Gaynor ◽  
Mark J. Ratain

Public scrutiny has increased over potential conflicts of interest among oncology researchers and providers. Given the increased prevalence and complexity of industry relationships, oncologists are increasingly faced with ethical challenges when navigating their financial relationships with industry. Oncologists are continually dealing with changing conflict of interest policies within academic centers and professional societies. With the recent passage of The Sunshine Act, oncologists are beginning to understand the repercussions of this new law. The consequences of the increasing use of direct-to-consumer advertising on patients with cancer are also unclear. Finally, industry's perspective on the evolution of these relationships is not clearly understood. This manuscript discusses issues related to industry's influence on oncology practice and research.


2019 ◽  
Vol 10 (3) ◽  
pp. e113-116
Author(s):  
Michael David Elfassy ◽  
Sharef Danho ◽  
Alexander Adibfar ◽  
Joel Lexchin

2003 ◽  
Vol 163 (15) ◽  
pp. 1808 ◽  
Author(s):  
Woodie M. Zachry III ◽  
James E. Dalen ◽  
Terrence R. Jackson

Sign in / Sign up

Export Citation Format

Share Document